Laekna Announces Largest 18A IPO Year to Date at HK$791 Million
June 29, 2023
Cooley advised China International Capital Corporation Hong Kong Securities Limited (CICC) and other underwriters on Laekna’s HK$791 million (US$101 million) initial public offering of 63,728,000 shares on the Hong Kong Stock Exchange, the largest 18A offering year to date.
Summit Healthcare Closes Business Combination With YS Biopharma
March 20, 2023
Cooley advised Summit Healthcare Acquisition Corp. (Summit Healthcare), a publicly traded special purpose acquisition company, on its business combination with YishengBio Co., Ltd. (YS Biopharma), a global biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of innovative vaccines and therapeutic biologics.
Cooley advised STAR CM, a variety program intellectual property creator and operator, on its HK$390 million ($50 million) initial public offering of 14,731,600 shares at a public offering price of HK$26.50 on the Hong Kong Stock Exchange, subject to the overallotment option.